The Role of High-Frequency Mutant Subunits of the SWI/SNF Complex in Tumors
Author Information
Author(s): Zhao Jiumei, Zhu Jing, Tang Yu, Zheng Kepu, Li Ziwei
Primary Institution: Chongqing Nanchuan District People’s Hospital, Chongqing, China
Hypothesis
Mutations in the SWI/SNF complex subunits, particularly ARID1A and SMARCA4, may introduce vulnerabilities to various cancers.
Conclusion
The study highlights the significant role of ARID1A and SMARCA4 mutations in tumorigenesis and their potential as targets for precise cancer therapies.
Supporting Evidence
- Approximately 25% of cancers have one or more SWI/SNF subunit genetic abnormalities.
- ARID1A is the most commonly mutated subunit in the SWI/SNF complex and is associated with various cancers.
- Mutations in ARID1A can lead to inactivation and absence of its protein expression, affecting tumor cell behavior.
Takeaway
Some parts of our cells that help control how genes work can get broken in cancer, and fixing these parts might help treat the disease better.
Methodology
The review summarizes existing research on the mechanisms of ARID1A and SMARCA4 in tumors and their implications for targeted therapy.
Limitations
The review does not provide new experimental data but synthesizes existing literature, which may not cover all recent findings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website